Equity Profile

ARGX

argenx SE

Health CareBiotechnology$53.6B

Jul23Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

argenx SE (ARGX) is a biotechnology company focused on developing innovative therapies for patients with severe autoimmune diseases and cancer. With a market cap of $54 billion, its advancements in antibody therapies are significant in the healthcare sector, especially as the demand for effective treatments continues to grow.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$5.52

Revenue Growth

While specific revenue estimates are not available, growth in revenue is crucial for sustaining the company's valuation and investor confidence.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ARGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+253.11%

Avg Stock Reaction

+0.79%

Last Quarter Recap

In Q1 2026, argenx reported an EPS of $5.52, surpassing estimates by 6.94%. However, the stock saw a decline of 2.51% the following day, indicating mixed market reactions despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's strong track record of beating EPS estimates. However, the lack of revenue guidance raises concerns about future growth.

Bull Case

If argenx continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, possibly leading to a significant stock price increase.

Bear Case

Conversely, if the company fails to provide clear guidance or if the earnings miss expectations, it could lead to a sharp decline in stock price, reflecting investor disappointment.

Key Metrics to Watch

Earnings Per Share (EPS)

$5.52

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

While specific revenue estimates are not available, growth in revenue is crucial for sustaining the company's valuation and investor confidence.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2 2026, and how does it compare to analyst expectations?

Given the company's history of beating EPS estimates, this number will be critical in shaping investor sentiment and stock performance.

Will there be any guidance on revenue growth for the upcoming quarters?

Revenue guidance is essential for understanding the company's future growth trajectory and could significantly impact investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for argenx to exceed EPS expectations again, given its strong historical performance.

Supporting Evidence

The company has a 100% EPS beat rate over the last eight quarters, indicating strong operational execution.

Options pricing suggests a higher expected move than historical averages, which may reflect investor uncertainty rather than confidence.

Key Risk

If the EPS comes in below $5.16, it could undermine the bullish sentiment and lead to a reevaluation of the stock's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued earnings growth against the uncertainty of revenue projections.

Bull Confirmed If

An EPS of $5.52 or higher, coupled with positive revenue guidance, would confirm the bull case.

Bear Confirmed If

An EPS below $5.16 or lack of revenue guidance would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.75%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a significant move of nearly 15%, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±14.7% while ARGX has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

31.0%

Calls (2K)P/C Ratio: 0.03Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If argenx beats expectations and raises guidance, history suggests a positive reaction with an average 1-day move of +0.79%.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see muted movement.

Miss

If the company misses EPS expectations, history suggests a potential decline, with an average 1-day move of -2.51% following past misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product developments or clinical trial results.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management and operational efficiencies.
4Any changes in strategic direction or partnerships.
5Future guidance on revenue growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Domino's Pizza, Inc.

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$5.52

Revenue Growth

While specific revenue estimates are not available, growth in revenue is crucial for sustaining the company's valuation and investor confidence.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ARGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+253.11%

Avg Stock Reaction

+0.79%

Last Quarter Recap

In Q1 2026, argenx reported an EPS of $5.52, surpassing estimates by 6.94%. However, the stock saw a decline of 2.51% the following day, indicating mixed market reactions despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If argenx continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, possibly leading to a significant stock price increase.

Bear Case

Conversely, if the company fails to provide clear guidance or if the earnings miss expectations, it could lead to a sharp decline in stock price, reflecting investor disappointment.

Key Metrics to Watch

Earnings Per Share (EPS)

$5.52

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

While specific revenue estimates are not available, growth in revenue is crucial for sustaining the company's valuation and investor confidence.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2 2026, and how does it compare to analyst expectations?

Given the company's history of beating EPS estimates, this number will be critical in shaping investor sentiment and stock performance.

Will there be any guidance on revenue growth for the upcoming quarters?

Revenue guidance is essential for understanding the company's future growth trajectory and could significantly impact investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for argenx to exceed EPS expectations again, given its strong historical performance.

Supporting Evidence

The company has a 100% EPS beat rate over the last eight quarters, indicating strong operational execution.

Options pricing suggests a higher expected move than historical averages, which may reflect investor uncertainty rather than confidence.

Key Risk

If the EPS comes in below $5.16, it could undermine the bullish sentiment and lead to a reevaluation of the stock's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued earnings growth against the uncertainty of revenue projections.

Bull Confirmed If

An EPS of $5.52 or higher, coupled with positive revenue guidance, would confirm the bull case.

Bear Confirmed If

An EPS below $5.16 or lack of revenue guidance would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.75%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a significant move of nearly 15%, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±14.7% while ARGX has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

31.0%

Calls (2K)P/C Ratio: 0.03Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If argenx beats expectations and raises guidance, history suggests a positive reaction with an average 1-day move of +0.79%.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see muted movement.

Miss

If the company misses EPS expectations, history suggests a potential decline, with an average 1-day move of -2.51% following past misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product developments or clinical trial results.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management and operational efficiencies.
4Any changes in strategic direction or partnerships.
5Future guidance on revenue growth and market expansion plans.